Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Nephrology & Renal DiseasesISSN: 2576-3962
https://sporbahisleri.livejournal.com https://wakelet.com/@SporBahisleri67459 https://theomnibuzz.com/author/sporbahisleri/ https://lessons.drawspace.com/profile/322207/sporbahisleri/workflow https://writeupcafe.com/profile/sporbahisleri/ http://www.pearltrees.com/sporbahisleri https://pharmahub.org/members/26874/blog https://www.zupyak.com/u/Spor-Bahisleri/ https://www.metroflog.co/sporbahisleri https://www.fuzia.com/fz/spor-bahisleri https://tr.pinterest.com/sporbahislerim/ https://my.getjealous.com/sporbahisleri https://sporbahisleri.contently.com https://hubpages.com/@sporbahisleri https://www.tumblr.com/sporbahisleri https://hub.docker.com/u/sporbahislerim https://betsiteleri.blogfree.net https://betsiteleri.amebaownd.com https://sporbahisleri.pixnet.net/blog https://betsiteleri.seesaa.net https://betsiteleri.threadless.com https://betsiteleri.neocities.org https://bahissiteleri.localinfo.jp https://betsiteleri.shopinfo.jp https://teletype.in/@betsiteleri https://ubl.xml.org/users/sporbahisleri https://betsiteleri.educatorpages.com https://betsiteleri.onlc.fr https://sporbahisleri.gumroad.com
N Mtioui Author
Publications
Annual Meeting Abstract Open Access
Kidney transplant from a donor brain death: single-center study
Author(s): N Mtioui
Introduction: In 2010, our structure had its 1st kidney transplants from donor brain death ( EME) after 20 years of transplants from living donors, opening with chronic renal failure terminals new therapeutic perspectives. Materials and methods: This is a single-center retrospective descriptive study of 9 years (September 2010-September 2019), colligeant all kidney transplant patients from a donor EME since the inception of this program. The aim of this study is to describe its epidemiological, clinical, surgical, treatment and outcome. Results: 35 patients were transplanted from a donor in EME, after a period of dialysis on average 5.91 years and an average waiting time of 2.7 years after enrollment on the waiting list, 53% were group O blood and 90% had no anti-HLA antibodies. The ave... view more»